Evolutionary Genomics, Inc. (FNAM)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - - 12.5 Thousand 122.68 Thousand 114.81 Thousand 32.69 Thousand
Cost of Revenue 1.02 Million 1.03 Million 1793.15 205.82 Thousand - -
Gross Profit -1.02 Million -1.03 Million 10.7 Thousand -83.14 Thousand 114.81 Thousand 32.69 Thousand
Operating Expenses 992.8 Thousand 2.87 Million 2.89 Million 897.51 Thousand 951.61 Thousand 1.33 Million
Selling, General and Administrative Expenses 1.59 Million 1.64 Million 1.09 Million 424.89 Thousand 477.62 Thousand 544.25 Thousand
Research and Development Expenses 417.45 Thousand 1.23 Million 1.79 Million 472.61 Thousand 473.99 Thousand 791.06 Thousand
Other Expenses - - 495.51 Thousand - 248.57 Thousand 272.89 Thousand
Cost and Expenses 2.01 Million 2.87 Million 2.89 Million 897.51 Thousand 951.61 Thousand 1.33 Million
Operating Income -2.01 Million -2.87 Million -2.87 Million -774.82 Thousand -836.79 Thousand -1.3 Million
Interest Expense - - - - - -
Income Tax Expense - -83.99 Thousand -987.35 Thousand 31.9 Thousand -261.81 Thousand -530.23 Thousand
Earnings before Tax -1.93 Million -2.79 Million -2.69 Million -761.23 Thousand -1.09 Million -1.06 Million
Net Income -2.24 Million -2.7 Million -1.71 Million -793.14 Thousand -1.09 Million -539.61 Thousand
Earnings Per Share Basic -0.35 -0.46 -0.29 -0.13 -0.19 -0.09
Earnings Per Share Diluted -0.35 -0.46 -0.29 -0.13 -0.19 -0.09
Weighted Average Shares Outstanding 6.42 Million 5.88 Million 5.88 Million 5.88 Million 5.88 Million 5.88 Million
Weighted Average Shares Outstanding (Diluted) 6.45 Million 5.88 Million 5.88 Million 5.88 Million 5.88 Million 5.88 Million
Gross Margin - - 0.86 -0.68 1.00 1.00
EBIT Margin - - -212.08 -6.09 -4.65 -45.66
Profit Margin - - -136.95 -6.46 -9.57 -16.51
EBITDA -913.47 Thousand -1.75 Million -2.47 Million -734.1 Thousand -795.72 Thousand -1.25 Million
Earnings Before Tax Margin - - -230.38 -6.32 -7.29 -39.85

Income Statement Charts